title: Adjuvant Immunotherapy and Radiation in the Management of High-risk Resected Melanoma.
abstract: Adjuvant therapy is widely used in melanoma cases because recurrence of disease after surgery is notoriously difficult to treat and usually results in the patient's death. Clinicians have a fundamental influence on the patient's decisions regarding adjuvant therapy, beginning with providing a clear understanding of the risk of specific types of recurrence based on features of the primary melanoma and status of the sentinel nodes and then explaining the morbidity of surgical treatment with and without adjuvant therapy. This review summarizes the role of adjuvant immunotherapy and radiation in the treatment of high-risk melanoma. We review the risks of specific types of recurrence as well as the potential oncologic benefits and relevant toxicities of available adjuvant therapies for high-risk melanoma.
authors: Ricardo J
authors: RJ
authors: Gonzalez
authors: Ragini
authors: R
authors: Kudchadkar
authors: Nikhil G
authors: NG
authors: Rao
authors: Vernon K
authors: VK
authors: Sondak
references: Lancet. 2008 Jul 12;372(9633):89-90
references: 18620932
references: Surgery. 2007 Jun;141(6):728-35
references: 17560249
references: Cancer Res. 2009 Apr 15;69(8):3241-4
references: 19351826
references: Arch Surg. 2002 Oct;137(10):1101-5
references: 12361412
references: J Clin Oncol. 2001 Aug 15;19(16):3622-34
references: 11504744
references: J Am Coll Surg. 2009 May;208(5):924-9; discussion 929-30
references: 19476863
references: Clin Cancer Res. 2004 Mar 1;10(5):1670-7
references: 15014018
references: N Engl J Med. 2006 Sep 28;355(13):1307-17
references: 17005948
references: Int J Radiat Oncol Biol Phys. 2009 Apr 1;73(5):1376-82
references: 18774657
references: Cancer. 2008 Nov 15;113(10):2770-8
references: 18823042
references: J Clin Oncol. 2001 May 1;19(9):2370-80
references: 11331315
references: J Clin Oncol. 2000 Apr;18(8):1614-21
references: 10764421
references: J Clin Oncol. 1996 Jan;14(1):7-17
references: 8558223
references: Nature. 2009 Sep 17;461(7262):399-401
references: 19684573
references: J Clin Oncol. 2007 Oct 10;25(29):4693; author reply 4693-5
references: 17925569
references: Lancet. 2008 Jul 12;372(9633):117-26
references: 18620949
references: Lancet Oncol. 2009 Apr;10(4):409-16
references: 19341972
references: Cancer J. 2006 May-Jun;12(3):207-11
references: 16803679
references: Cancer. 2009 Dec 15;115(24):5836-44
references: 19701906
references: Int J Radiat Oncol Biol Phys. 2006 Nov 15;66(4):1051-5
references: 16973303
references: Head Neck. 2003 Jun;25(6):423-8
references: 12784232
references: Ann Surg. 2002 Jun;235(6):879-87
references: 12035046
references: Cancer Control. 2005 Oct;12(4):230-5
references: 16258494
references: Cancer. 2005 Oct 1;104(7):1462-7
references: 16080180
references: Ann Oncol. 2006 Oct;17(10):1578-85
references: 16968875
references: Ann Surg Oncol. 2008 Mar;15(3):683-90
references: 18183467
references: Ann Surg Oncol. 2008 Feb;15(2):630-7
references: 18080717
references: J Am Acad Dermatol. 2001 May;44(5):762-6
references: 11312421
references: Ann Surg Oncol. 2010 Feb;17(2):358-61
references: 19941082
references: J Am Acad Dermatol. 2009 May;60(5):872-5
references: 19389531
references: J Clin Oncol. 2007 Mar 20;25(9):1129-34
references: 17369575
references: J Natl Compr Canc Netw. 2004 Jan;2(1):69-72
references: 19777696
references: J Clin Oncol. 2002 Apr 15;20(8):2058-66
references: 11956266
references: Cancer Control. 2009 Jul;16(3):240-7
references: 19556964
references: J Clin Oncol. 2009 Jun 1;27(16):2583-5
references: 19364958
references: J Clin Oncol. 2001 Feb 1;19(3):812-23
references: 11157035
references: J Clin Oncol. 2009 Feb 20;27(6):939-44
references: 19139440
references: J Clin Oncol. 2005 Sep 1;23(25):6054-62
references: 16135473
references: Nat Rev Clin Oncol. 2009 May;6(5):256-8
references: 19390551
references: Ann Surg Oncol. 2008 Jan;15(1):316-22
references: 18004626
references: Oncology (Williston Park). 2004 Jan;18(1):99-107; discussion 107-10, 113-4
references: 14768409
references: J Clin Oncol. 2009 Dec 20;27(36):6199-206
references: 19917835
references: J Clin Oncol. 2000 Jun;18(12):2444-58
references: 10856105
references: Ann Surg Oncol. 2004 Mar;11(3):247-58
references: 14993019
references: J Natl Cancer Inst. 2010 Apr 7;102(7):493-501
references: 20179267
references: J Clin Oncol. 2008 Jul 1;26(19):3235-41
references: 18591558
references: Ann Surg Oncol. 2008 Nov;15(11):3014-21
references: 18716842